ArticleHematology, transfusion and cell therapy2024

Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome-A propensity score matched analysis.

André Dias Américo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.